In an announcement on February 25, GE announced the proposed sale of parts of the current Life Sciences business to US-based Danaher Corporation. The transaction, is subject to customary closing conditions, including regulatory reviews and appropriate consultation processes, and is expected to be complete by 4Q 2019. Testa Center, as a non-profit company owned and operated by …

Continue reading “GE to sell Bio-Pharma Business to Danaher”

Testa Center in 100 words

We offer businesses and academia globally a modern, pilot-scale testbed for projects and education in production of biological products e.g. monoclonal antibodies, peptides, protein, vaccine and viral vectors (non-GMP, up to Bio-safety level 2 and 500 liter).

In our flexible facility, and with some helping hands of our experienced staff, you can perform a wide variety of projects, including scale-up of parts of a process, or a complete process from frozen cell bank vial to purified protein.

Testa Center is a major initiative between the Swedish government and Cytiva (formerly GE Life Sciences) to secure the growth of life science industry and its manufacturing capabilities. Main objective for Testa Center is to bridge the gap from discovery to industrialization.

Testa Center is operated as a non-profit company, owned by Cytiva.